论文信息 - Five-year survival of patients in control groups of randomized controlled trials is much higher than that assumed in observational study reports - 字舞流文

Five-year survival of patients in control groups of randomized controlled trials is much higher than that assumed in observational study reports

J. Dunning | T. Treasure | J. Edwards | M. Shackcloth | M. Milošević

[1] G. Alí,et al. Lung metastasectomy after colorectal cancer: prognostic impact of resection margin on long term survival, a retrospective cohort study , 2019, International Journal of Colorectal Disease.

[2] J. Dunning,et al. Pulmonary Metastasectomy versus Continued Active Monitoring in Colorectal Cancer (PulMiCC): a multicentre randomised clinical trial , 2019, Trials.

[3] Michael Lock,et al. Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): a randomised, phase 2, open-label trial , 2019, The Lancet.

[4] M. Delgado-Rodríguez,et al. Systematic review and meta-analysis. , 2017, Medicina intensiva.

[5] C. Combescure,et al. Risk Factors for Survival after Lung Metastasectomy in Colorectal Cancer Patients: A Systematic Review and Meta-Analysis , 2013, Annals of Surgical Oncology.

[6] J. Ledermann,et al. Radiofrequency ablation combined with systemic treatment versus systemic treatment alone in patients with non-resectable colorectal liver metastases: a randomized EORTC Intergroup phase II study (EORTC 40004). , 2011, Annals of oncology : official journal of the European Society for Medical Oncology.

[7] B. Nilsson,et al. The effect of metastasectomy: fact or fiction? , 1980, The Annals of thoracic surgery.